FDA inspection
Amgen, Inc.: FDA inspection ending Sep 14, 2023
FDA inspection 1220409 · No Action Indicated (NAI) · Thousand Oaks, CA
Key facts
| Inspection ID | 1220409 |
|---|---|
| Firm | Amgen, Inc. |
| FEI number | 2026154 |
| Address | 1 Amgen Center Dr |
| City | Thousand Oaks |
| State | CA |
| ZIP | 91320 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Sep 14, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data